A Randomized, Double Blind, Placebo‐Controlled Trial of an Oral Synbiotic (AKSB) for Prevention of Travelers' Diarrhea

ConclusionsThe prophylactic oral synbiotic was safe but did not reduce the risk of developing TD among travelers, nor did it decrease the duration of TD or the use of antibiotics when TD occurred.

Source: Journal of Travel Medicine - January 25, 2013 Category: Infectious Diseases Authors: Abinash Virk, Jayawant Mandrekar, Elie F. Berbari, Thomas G. Boyce, Philip R. Fischer, Mary J. Kasten, Robert Orenstein, Jon E. Rosenblatt, Priya Sampathkumar, Irene Sia, Donna Springer, Thomas E. Witzig Tags: ORIGINAL ARTICLE Source Type: research